Skip to main content

Table 1 Demografic and spirometric data patients with IPF and sarcoidosis

From: Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis

  Sarcoidosis total IPF Controls
N = 43 (20 F/ 23 M) N = 17 (7 F/ 10 M) N = 20 (10 F/10 M)
(mean ± SEM) (mean ± SEM) (mean ± SEM)
Median (Interquartile range) Median (Interquartile range) Median (Interquartile range)
Age (years)    
35.7 ± 1.3 58.3 ± 1.6 *** 34.3 ± 1.2
33.5 (29.5–40.0) 58.0 (53.7–64.0) 33.5 (29.5–37.5)
BMI (kg/m2) 26.9 ± 0.5 27.4 ± 0.7 27.2 ± 0.6
27.0 (23.2–31.4) 27.6 (21.2–31.3) 27.1 (22.3–30.1)
FEV1 (% of predicted)    
86.1 ± 1.6 67.9 ± 2.3 **  
85.5 (81.0–93.0) 69.0 (61.0–77.3)  
FVC (% of predicted)    
96.2 ± 2.1 70.3 ± 1.8 **  
98.0 (88.5–104.0) 69.0 (63.5–79.0)  
FEV1%VC (%)    
75.7 1.0 77.0 ± 1.8  
75.0 (71.0–80.0) 76 (73.5–82.3)  
  1. F females, M males, IPF idiopathic pulmonary fibrosis, FEV1 Forced expiratory volume in 1 s
  2. FVC Forced Vital Capacity, FEV1%VC forced expiratory volume in one second % of vital capacity **p < 0.001 IPF vs sarcoidosis ***p < 0.001 IPF vs controls and sarcoidosis